The SpineCor system is a flexible brace that is
principally prescribed for Idiopathic Scoliosis patients with
a Cobb angle between 15° and 50° and Risser sign 0 to 3.
The brace is fitted on the patient in accordance to a
sub-classification of the traditional SRS definition of curve
types. The SpineCor Assistant Software guides the
treatment provider through the fitting process. The
brace is prescribed to be worn by the patients 20 out of 24
hours per day until they have reached maturity, with
radiological evaluations performed prior to and immediately
following the fitting of the brace, and every 4 to 6 months
afterwards. To accommodate for growth and postural
changes, corrective bands need to be adjusted frequently and
require replacement each 6-12 months for optimum brace
performance. Major brace components can last from 1.5 -
2 years. A patient manual is provided that guides the
patient in properly wearing the brace, as well as
maintenance. The SpineCor brace must only be fitted by a
SpineCor accredited practitioner who has attended 4 days of
intensive training and fitted a minimum number of patients
under supervision. It is also suggested that prescribing
doctors attend some training in order to effectively monitor
and manage this treatment using very different treatment
principles and protocols.
INDICATIONS
The SpineCor System was designed, developed, and tested
for the treatment of idiopathic scoliosis. Its efficacy
for treating neuromuscular, neurological and other types of
scoliosis has not been evaluation and is generally
contraindicated.
CONCEPT
The therapeutic approach is based on the etiology and
pathogenesis of idiopathic scoliosis and uses a new treatment
concept. It is a pathology of the neuro-musculoskeletal
system in growth and maturation. The cause is genetic,
and the pathogenesis involves a three-dimensional deformation
of the spine, postural disorganization, unsynchronized growth
and particular movement pattern of the
body.
DIAGNOSIS
In order to obtain an accurate diagnosis, that would
specify a particular class and subclass for the patient, the
evaluation combines a clinical exam, radiological and postural
evaluation.
TREATMENT
A specific corrective movement is performed, and the
brace is applied according to the SpineCor Assistant Software
instructions. The moderate tension in the elastic bands allows
the repetition and amplification of the corrective movement as
the child undertakes everyday activities. This results in a
progressive curve reduction. The brace is worn 20 hours
out of 24. The four hours out of the brace must not be taken
at once, usually the patient divides them into two breaks:
morning and evening. Sports are to be encouraged and
done while wearing the brace. To obtain a
neuro-muscular integration of the new strategy of movement,
the minimum duration of the treatment is 18 months.
Because of the progressive changes, absence of external
support during the treatment, and intact muscles, there is no
loss of correction after the brace discontinuation.
Physical therapy is NOT a necessity in the SpineCor program
(SpineCor itself may be considered a physiotherapy
20 hours out of 24). However, when the patient is
willing to undergo a physio program, or a faster consolidation
of the reduction of the curve is desired, the Global Postural
Re-education (GPR) program is considered. For the
patients at the beginning of the treatment, the physio is
carried out with the brace on; for the patients in the weaning
period the exercises are done without the
brace.
PROGNOSIS
To really change the natural progression of idiopathic
scoliosis, it is essential to reduce the curvature enough to
eliminate the negative impact of abnormal biomechanics and
growth. Therefore, it is possible to achieve a complete
or almost complete correction of moderate curves, if the
treatment is started before the main growth spurt (before
Risser 1 and menarche). In curves over 30 degrees of
Cobb angle, or when the treatment started during or after the
main growth spurt, the goal of the treatment is a
stabilization of the deformity. The therapeutic success
is possible in more than 80% of cases. The reference
reducibility calculated as early as at 3/4 months of
treatment, is useful in defining the prognosis. However,
for individual prognoses, the impact of the severity of the
bone deformation, pattern of the growth and compliance must be
considered.